Queue Ventures Granted Conditional TSX Approval
Queue Ventures Ltd. has received conditional approval from the Toronto Stock Exchange (TSX) in connection with its proposed business combination with Custom Health.
This marks a key step toward becoming a publicly traded company and advancing a scalable, infrastructure-led model for medication management and clinical care.
The transaction remains subject to final TSX approval and customary closing conditions.
Read the full release: Access Newswire
This update includes forward-looking statements regarding the proposed transaction and listing. Actual results may differ materially.